4th Quarter - Report

THE DUBERSTEIN GROUP INC. for PFIZER INC.

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

National Institute of Health funding for Alzheimer's disease - HR 2055, Consolidated Appropriations Act, 2012.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2055 (112th)

Trade (domestic/foreign) TRD

US-Korea Free Trade Agreement - HR 3080, United States-Korea Free Trade Agreement Implementation Act (PL 112-41).

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3080 (112th)

Taxation/Internal Revenue Code TAX

Corporate tax reform, including international taxes and tax extenders - Proposed legislation re these issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
ERIC UELAND —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Impact of deficit reduction issues, and actions of the Joint Committee on Deficit Reduction on Medicare, Medicare Part B, and Medicare Part D - Proposed legislation re these issues. Sustainable growth rate and impact on other Medicare programs - HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3765 (112th), H.R. 3630 (112th)

Pharmacy PHA

Reimported drugs from Canada - HR 2112, Consolidated and Further Continuing Appropriations Act, 2012. Counterfeit drug penalty enforcement act - S 1886, Counterfeit Drug Penalty Enhancement Act of 2011. Patent and generic drugs - Congressional investigation re this issue.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2112 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.